Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

PHASE3RecruitingINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

September 6, 2022

Primary Completion Date

November 2, 2026

Study Completion Date

November 30, 2026

Conditions
Hypereosinophilic Syndrome
Interventions
DRUG

Depemokimab

Depemokimab will be administered.

OTHER

Placebo

Matching placebo will be administered.

Trial Locations (78)

1070

RECRUITING

GSK Investigational Site, Brussels

1602

RECRUITING

GSK Investigational Site, Florida

1878

RECRUITING

GSK Investigational Site, Quilmes

2606

COMPLETED

GSK Investigational Site, Garran

5000

RECRUITING

GSK Investigational Site, Odense C

7600

RECRUITING

GSK Investigational Site, Mar del Plata

10676

RECRUITING

GSK Investigational Site, Athens

11030

RECRUITING

GSK Investigational Site, Manhasset

14059

RECRUITING

GSK Investigational Site, Prague

16499

RECRUITING

GSK Investigational Site, Suwon Kyunggi-do

18014

RECRUITING

GSK Investigational Site, Granada

20132

RECRUITING

GSK Investigational Site, Milan

26054

RECRUITING

GSK Investigational Site, Rio Patras

26426

RECRUITING

GSK Investigational Site, Kangwondo

28008

RECRUITING

GSK Investigational Site, Madrid

28031

RECRUITING

GSK Investigational Site, Madrid

28100

RECRUITING

GSK Investigational Site, Novara

29425

RECRUITING

GSK Investigational Site, Charleston

30322

RECRUITING

GSK Investigational Site, Atlanta

31100

RECRUITING

GSK Investigational Site, Treviso

31281

RECRUITING

GSK Investigational Site, Bucharest

37007

RECRUITING

GSK Investigational Site, Salamanca

37134

RECRUITING

GSK Investigational Site, Verona

37208

COMPLETED

GSK Investigational Site, Nashville

44130

RECRUITING

GSK Investigational Site, Guadalajara

45229

RECRUITING

GSK Investigational Site, Cincinnati

46026

RECRUITING

GSK Investigational Site, Valencia

48075

WITHDRAWN

GSK Investigational Site, Southfield

50009

RECRUITING

GSK Investigational Site, Zaragoza

52621

RECRUITING

GSK Investigational Site, Ramat Gan

55905

RECRUITING

GSK Investigational Site, Rochester

61469

RECRUITING

GSK Investigational Site, Gwangju

64060

RECRUITING

GSK Investigational Site, Monterrey

64239

RECRUITING

GSK Investigational Site, Tel Aviv

68167

RECRUITING

GSK Investigational Site, Mannheim

80131

RECRUITING

GSK Investigational Site, Napoli

84132

RECRUITING

GSK Investigational Site, Salt Lake City

94534

RECRUITING

GSK Investigational Site, Veracruz

95123

RECRUITING

GSK Investigational Site, Catania

100730

RECRUITING

GSK Investigational Site, Beijing

150010

RECRUITING

GSK Investigational Site, Harbin

200025

RECRUITING

GSK Investigational Site, Shanghai

215006

RECRUITING

GSK Investigational Site, Suzhou

330006

RECRUITING

GSK Investigational Site, Nanchang

400124

RECRUITING

GSK Investigational Site, Cluj-Napoca

410008

RECRUITING

GSK Investigational Site, Changsha

430022

RECRUITING

GSK Investigational Site, Wuhan

510080

RECRUITING

GSK Investigational Site, Guangzhou

510515

RECRUITING

GSK Investigational Site, Guangzhou

C1425BEN

RECRUITING

GSK Investigational Site, Buenos Aires

B1900

RECRUITING

GSK Investigational Site, La Plata

89030-101

RECRUITING

GSK Investigational Site, Blumenau

90035-903

RECRUITING

GSK Investigational Site, Porto Alegre

18040-425

RECRUITING

GSK Investigational Site, Sorocaba

625 00

RECRUITING

GSK Investigational Site, Brno - Bohunice

500 05

RECRUITING

GSK Investigational Site, Hradec Králové

Unknown

RECRUITING

GSK Investigational Site, Pokfulam

00168

RECRUITING

GSK Investigational Site, Roma

030-8553

RECRUITING

GSK Investigational Site, Aomori

036-8563

RECRUITING

GSK Investigational Site, Aomori

272-8516

RECRUITING

GSK Investigational Site, Chiba

509-6134

RECRUITING

GSK Investigational Site, Gifu

670-8540

RECRUITING

GSK Investigational Site, Hyōgo

259-1143

RECRUITING

GSK Investigational Site, Kanagawa

980-8574

RECRUITING

GSK Investigational Site, Miyagi

105-8471

RECRUITING

GSK Investigational Site, Tokyo

142-8666

RECRUITING

GSK Investigational Site, Tokyo

409-3898

RECRUITING

GSK Investigational Site, Yamanashi

90-153

RECRUITING

GSK Investigational Site, Lodz

561-712

RECRUITING

GSK Investigational Site, Jeonju

03722

RECRUITING

GSK Investigational Site, Seoul

06351

RECRUITING

GSK Investigational Site, Seoul

06591

RECRUITING

GSK Investigational Site, Seoul

110-744

RECRUITING

GSK Investigational Site, Seoul

136-705

RECRUITING

GSK Investigational Site, Seoul

138-736

RECRUITING

GSK Investigational Site, Seoul

08036

RECRUITING

GSK Investigational Site, Barcelona

LE3 9QP

RECRUITING

GSK Investigational Site, Leicester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT05334368 - Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial | Biotech Hunter | Biotech Hunter